Clinical trials recruiting in Denizli, Turkey (Türkiye)
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 4Not applicable 4
Conditions recruiting in Denizli, Turkey (Türkiye)
Recruiting trials in Denizli, Turkey (Türkiye)
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Sexual Functıon in Young Women After Breast Cancer Surgery
- Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty
- The Investigation of Kinesiophobia in Conservative Distal Radius Fractures
Common questions
How many clinical trials are recruiting in Denizli, Turkey (Türkiye)?
9 recruiting trials have at least one study site in Denizli, Turkey (Türkiye).
Is this list complete?
No. For the full record, search ClinicalTrials.gov.